Andrew Goetze

Title: Andrew Goetze: Innovator in Antibody Production

Introduction

Andrew Goetze is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant antibodies. His work focuses on enhancing the recovery and enrichment of preferred forms of IgG proteins, which are crucial for various therapeutic applications.

Latest Patents

Andrew Goetze holds a patent titled "Methods for refolding of recombinant antibodies." This invention is directed towards methods that increase the enrichment or recovery of preferred forms of IgG proteins. The process involves subjecting preparations of recombinant IgG proteins to a reduction/oxidation coupling reagent, and optionally, a chaotropic agent. This innovative approach has the potential to improve the efficiency of antibody production.

Career Highlights

Goetze is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen allows him to apply his expertise in antibody production and contribute to the development of new treatments. His work is instrumental in advancing the field of biotechnology and improving patient outcomes.

Collaborations

Throughout his career, Andrew has collaborated with esteemed colleagues, including Thomas M. Dillon and Douglas Rehder. These collaborations have fostered a productive environment for innovation and have led to advancements in the field of recombinant antibody production.

Conclusion

Andrew Goetze is a prominent figure in the biotechnology sector, with a focus on improving the production of recombinant antibodies. His patent and work at Amgen Inc. highlight his commitment to innovation in this critical area of research. His contributions are paving the way for advancements in therapeutic applications of antibodies.